Literature DB >> 19568610

A case of suspected isotretinoin-induced malformation in a baby of a mother who became pregnant one month after discontinuation of the drug.

Soon Min Lee1, He Min Kim, Jun Seok Lee, Choon Sik Yoon, Min Soo Park, Kook In Park, Ran Namgung, Chul Lee.   

Abstract

Isotretinoin is a known human teratogen that can cause multiple malformations. At present, women who conceive one cycle after discontinuing isotretinoin are told that their teratogenic risk is not higher than baseline. We present a case of both-ear malformation in a newborn whose mother had taken isotretinoin for 2 years until one month prior to the time when she became pregnant. We suggest that further studies of pharmacokinetics and malformation of isotretinoin are needed.

Entities:  

Keywords:  Isotretinoin; malformation

Mesh:

Substances:

Year:  2009        PMID: 19568610      PMCID: PMC2703771          DOI: 10.3349/ymj.2009.50.3.445

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  10 in total

1.  Accutane-exposed pregnancies--California, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-01-21       Impact factor: 17.586

Review 2.  Can we ensure the safe use of known human teratogens?: The iPLEDGE test case.

Authors:  Margaret A Honein; Jill A Lindstrom; Sandra L Kweder
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Retinoic acid embryopathy: timing of exposure and effects on fetal development.

Authors:  J H Hersh; D E Danhauer; M E Hand; B Weisskopf
Journal:  JAMA       Date:  1985-08-16       Impact factor: 56.272

4.  Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.

Authors:  Allen Brinker; Cynthia Kornegay; Parivash Nourjah
Journal:  Arch Dermatol       Date:  2005-05

5.  Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety.

Authors:  I Nulman; M Berkovitch; J Klein; A Pastuszak; R S Lester; N Shear; G Koren
Journal:  J Clin Pharmacol       Date:  1998-10       Impact factor: 3.126

6.  Safety of pregnancy after discontinuation of isotretinoin.

Authors:  W S Dai; M A Hsu; L M Itri
Journal:  Arch Dermatol       Date:  1989-03

7.  Isotretinoin embryopathy and the cranial neural crest: an in vivo and in vitro study.

Authors:  W S Webster; M C Johnston; E J Lammer; K K Sulik
Journal:  J Craniofac Genet Dev Biol       Date:  1986

8.  A pregnancy-prevention program in women of childbearing age receiving isotretinoin.

Authors:  A A Mitchell; C M Van Bennekom; C Louik
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

9.  Microtia in Finland: comparison of characteristics in different populations.

Authors:  Samuli Suutarla; Jorma Rautio; Annukka Ritvanen; Sirpa Ala-Mello; Jussi Jero; Tuomas Klockars
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2007-06-04       Impact factor: 1.675

10.  Maternal and neonatal effects of substance abuse during pregnancy: our ten-year experience.

Authors:  Mirjana Vucinovic; Damir Roje; Zoran Vucinovic; Vesna Capkun; Marija Bucat; Ivo Banovic
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

  10 in total
  5 in total

Review 1.  Pregnancy and isotretinoin therapy.

Authors:  June Seek Choi; Gideon Koren; Irena Nulman
Journal:  CMAJ       Date:  2013-01-07       Impact factor: 8.262

2.  Retinoic Acid Embryopathy.

Authors:  Dipankar Mondal; Sreekanth R Shenoy; Santisena Mishra
Journal:  Int J Appl Basic Med Res       Date:  2017 Oct-Dec

3.  Washout Period for Pregnancy Post Isotretinoin Therapy.

Authors:  Hina Jajoria; Venkataram Mysore
Journal:  Indian Dermatol Online J       Date:  2020-03-09

4.  Taussig-Bing Anomaly in a Premature Neonate with Isotretinoin Embryopathy.

Authors:  Nurdan Uras
Journal:  Turk Arch Pediatr       Date:  2021-07-01

5.  The age-old problem of acne.

Authors:  N F Mahmood; A R Shipman
Journal:  Int J Womens Dermatol       Date:  2016-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.